Gabapentinoids: Considerations on their contextual harmfulness and psychological dependence potential
Author:
- 10 November 2024
- journal article
- research article
- Published by Elsevier in International Journal of Drug Policy
- Vol. 134, 104655
Abstract
No abstract availableThis publication has 13 references indexed in Scilit:
- Experiences of misuse and symptoms of dependence among people who use gabapentinoids: A qualitative systematic reviewInternational Journal of Drug Policy, 2024
- Opioid problems are changing in Europe with worrying signals that synthetic opioids may play a more significant role in the futureAddiction, 2023
- The Role of Gabapentinoids in the Substance Use Pattern of Adult Germans Seeking Inpatient Detoxification Treatment – A Pilot StudyJournal of Psychoactive Drugs, 2022
- How prevalent and severe is addiction on GABAmimetic drugs in an elderly German general hospital population? Focus on gabapentinoids, benzodiazepines, and z‐hypnotic drugsHuman Psychopharmacology: Clinical and Experimental, 2021
- Non-medical Use of Prescription Gabapentinoids (Gabapentin and Pregabalin) in Five European CountriesFrontiers in Psychiatry, 2021
- Abuse and Misuse of Pregabalin and Gabapentin: A Systematic Review UpdateDrugs, 2020
- Ranking the Harm of Psychoactive Drugs Including Prescription Analgesics to Users and Others–A Perspective of German Addiction Medicine ExpertsFrontiers in Psychiatry, 2020
- Gabapentinoid Benefit and Risk Stratification: Mechanisms Over MythPain and Therapy, 2020
- How addictive are gabapentin and pregabalin? A systematic reviewEuropean Neuropsychopharmacology, 2017
- Ketamine Attenuates and Reverses Morphine Tolerance in RodentsAnesthesiology, 1996